This complexity explains in part why, for instance, activation of the M3R subtype has been shown to promote cancer cell proliferation in gastric cancer, whereas activation of M1R subtype has been shown to attenuated pancreatic cancer proliferation. Here, CHRM1 is linked to pancreatic neoplasm.